Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma

Federal Research Institute of Pediatric Hematology, Oncology and Immunology · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
neuroblastoma (nb), ganglioneuroblastoma, refractory/relapsed neuroblastoma, children, autologous nk cells, chemoimmunotherapy, dinutuximab beta, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 993133
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.